New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease.
Open accessAbstract
The hypothesis, some 30 years ago, that NE was the sole proteolytic agent responsible for the development of emphysema seems naive in retrospect. The availability of technology to measure NE facilitated the early research into the relationship between NE and lung disease. Despite an abundance of information on the activity of NE in the lung, it will probably require prospective studies in man with specific NE inhibitors or control at the gene level to establish a causal relationship between NE and lung disease. Parallel research has resulted in the isolation and characterisation of NE inhibitors other than PI and, indeed, alternative proteolytic enzymes that might contribute to lung disease. It is perhaps impossible now to think that a single proteinase, however omnipotent it may be, causes lung diseases as diverse as emphysema and fibrosis. An important aspect that is emerging is the interrelationship between proteolytic enzymes produced by different, or sometimes the same, cells that could potentiate tissue proteolysis. The evidence suggests that there is likely to be coordinated action between neutrophils, macrophages, and possibly mesenchymal proteinases which can activate or inactivate each other. In addition, one class of proteinases often appears able to proteolytically inactivate inhibitors of the opposite class, which presumably could amplify proteolysis if it occurred in vivo. Although the work on this aspect of proteinase activity is in its infancy, one suspects that part of the normal regulation of proteinase activity might include compartmentalisation. For example, the neutrophil stores proteinases before appropriate release and can inactivate PI to enable proteolytic action pericellularly, whereas degradation of extracellular matrix by macrophages requires interaction between the cell and matrix which is facilitated by cell receptor bound uPA. Disintegration of these "compartments" due to oedema, proteolysis, or for mechanical reasons could, firstly, expose further extracellular matrix substrates to inflammatory and damaged cell proteinases but, secondly, might enhance proteinase potential by the cooperative action of these enzymes. It seems increasingly likely that, where proteinases play a part, there is a cocktail of proteinases that is characteristic of the injury that develops (fig). What remains unclear is why only a proportion of those susceptible, such as smokers or those with acute lung injury, develop irreversible lung disease. This suggests that there are other factors acquired or inherited that need to be considered.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
HNE is a causal factor in the progression of emphysema and chronic obstructive pulmonary disease (COPD).
“However, HNE is also a causal factor in the progression of emphysema and chronic obstructive pulmonary disease (COPD) [6,7] due to the enzyme’s propensity to propagate cyclic inflammation, recruit neutrophils, and proteolytically destroy elastic lung tissue [8,9].”
From Discrimination of Methionine Sulfoxide and Sulfone by Human Neutrophil Elastase (2021) · cites this paper as [7]
The emphysema discussion proposes neutrophil elastase (NE, also called HNE) as a key contributor to tissue damage, and the airways-disease discussion links NE activity to chronic obstructive airways disease. But the Summary says prospective human studies are needed to establish a causal relationship between NE and lung disease. The source therefore does not establish HNE as a causal factor in the progression of emphysema and COPD. (LLM, conf=0.89)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 66
- Harada RN, Repine JE. Pulmonary host defence mecha- nisms. Chest 1985;87:247-52.
- Henson PM, Johnston RB. Tissue injury in inflammation: oxidants, proteinases and cationic proteins. J Clin Invest 1987;79:669-74.
- Haslett C. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci 1992;83:639-48.
- Weiss SJ. Tissue destruction by neutrophils. N EnglJ7 Med 1989;320:365-76.
- Savill J. Macrophage recognition of senescent neutrophils. Clin Sci 1992;83:649-55.
- Barrett AJ, Kirschke H. Cathepsin B, cathepsin H and cathepsin L. Methods Enzymol 1980;80:535-65.
- Clausbruch UCV, Tschesche H. Cathepsin D from human leukocytes. Biol Chem Hoppe Seyler 1988;369: 683-91.
- Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitor. Am J Respir Cell Mol Biol 1992;7: 120-5.
- Senior RM, Connelly NL, Cury JD, Welgus HG, Campbell EJ. Elastin degradation by human alveolar macrophages: a prominent role of metalloproteinase activity. Am Rev RespirDis 1989;139:1251-6.
- Laurell C-B, Eriksson S. The electrophoretic alpha,-glob- ulin pattern of serum in alpha,-antitrypsin deficiency. Scandj Lab Clin Med 1963;15:132-40.
- Carrell RW, Jeppsson J-O, Laurell C-B, Brennan SO, Owen MC, Vaughan L, et al. Structure and variation of human a,-antitrypsin. Nature 1982;298:329-34.
- Janoff A, Sloan B, Weinbaum G, Damiano V, Sandhaus RA, Elias J, et al. Experimental emphysema induced with purified human neutrophil elastase: tissue localisa- tion of the instilled protease. Am Rev Respir Dis 1977;115:461-78.
- Kramps JA, Rudolphus A, Stolk J, Willems LNA, Dijkman JH. Role of antileukoprotease in the lung. Ann NYAcad Sci 1991;624:97-108.
- Tetley TD. Emphysema revisited. Respir Med 1992;86: 187-93.
- Damiano VV, Tang A, Kuchic U, Abrams WR, Rosenbloom J, Kimbel P, et al. Immunolocalisation of elastase in human emphysematous lungs. J Clin Invest 1986;78:482-93.
- Fox B, Bull TB, Guz A, Harris E, Tetley TD. Is neutro- phil elastase associated with elastic tissue in emphy- 564 on November 1, 2023 by guest. Protected by copyright. http://thorax.bmj.com/ Thorax: first published as 10.1136/thx.48.5.560 on 1 May 1993. Downloaded from Protein imbalance: its role in lung disease sema? Clin Pathol 1988;41:435-40.
- Snider GL, Ciccolella DE, Morris SM, Stone PJ, Lucey EC. Putative role of neutrophil elastase in the pathogen- esis of emphysema. Ann NYAcad Sci 1991;624:45-59.
- Smith SF, Guz A, Cooke NT, Burton GH, Tetley TD. Extracellular elastolytic activity in human lung lavage: a comparative study between smokers and non-smokers. Clin Sci 1985;69:17-27.
- Fera T, Abboud RT, Ritcher A, Johal SS. Acute effect of smoking on elastase-like esterase activity and immuno- logical neutrophil elastase levels in bronchoalveolar lavage fluid. Am Rev RespirDis 1986;133:568-73.
- Tetley TD, Smith SF, Winning AJ, Foxall JM, Cooke NT, Burton GH, et al. The acute effect of cigarette smoking on the neutrophil elastase inhibitory capacity of peripheral lung lavage from asymptomatic volunteers. Eur RespirJ 1989;2:802-10.
- Fujita J, Nelson NL, Daughton DM, Dobry CA, Spurzem JR, Irino S, et al. Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pul- monary emphysema. Am Rev Respir Dis 1990;142: 57-62.
- Weitz JI, Silverman EK, Thong B, Campbell EJ. Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. Evidence for increased elastase activity in subjects with homozygous and heterozygous deficiency of alpha l-proteinase inhibitor. JfClin Invest 1992;89:766-73.
- Simon RH, DeHart PD, Todd RF. Neutrophil-induced injury of rat pulmonary alveolar epithelial cells. Clin Invest 1986;78: 1375-86.
- Bingle L, Richards RJ, Fox B, Masek L, Guz A, Tetley TD. Differential effects of neutrophil elastase and its inhibitors on alveolar and bronchiolar epithelial cell adherence in vitro. Am Rev Respir Dis 1990;141:A682.
- Hubbard RC, Brantley ML, Crystal RG. Proteases. In: Crystal RG, West JB, et al, eds. The lung. New York: Raven Press, 1991:1763-73.
- Lewis RW, Harwood JL, Tetley TD, Harris E, Richards RJ. Degradation of human and rat surfactant apoprotein by neutrophil elastase and cathepsin G. Biochem Soc Trans 1992;21:206S.
- Rao NV, Wehner NG, Marshall BC, Sturrock AB, Huecksteadt TP, Rao GV, et al. Proteinase-3 (PR-3): a polymorphonuclear leukocyte proteinase. Ann NY Acad Sci 1991;624:60-8.
- Boudier C, Godeau G, Homebeck W, Robert L, Bieth JG. The elastolytic activity of cathepsin G: an ex vivo study with dermal elastin. Am Jf Respir Cell Mol Biol 199 1;4:497-503.
- Poller W, Faber JP, Scholz S, Weidinger S, Bartholome K, Olek K, et al. Mis-sense mutation of alpha 1-anti- chymotrypsin gene associated with chronic lung disease. Lancet 1992;339:1538.
- Okada Y, Watanabe S, Nakanishi I, Kishi J, Hayakama T, Watorek W, et al. Inactivation of tissue inhibitor of met- alloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett 1988;229: 157-60.
- Banda MJ, Werb Z. Mouse macrophage elastase. Purification and characterisation as a metalloproteinase. Biochem Jf 1981;193:589-605.
- Matrisian LM. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genetics 1990;6: 121-5.
- Estreicher A, Muhlhauser J, Carpentier J-L, Orci L, Vassalli J-D. The receptor for urokinase plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J7 Cell Biol 1990;111:783-92.
- Chapman HA. Role of enzyme receptors and inhibitors in regulating proteolytic activities of macrophages. Ann NYAcad Sci 1991;624:87-96.
- Breuer R, Lucey EC, Stone PJ, Christensen TG, Snider GL. Proteolytic activity of human neutrophil elastase and porcine pancreatic trypsin causes bronchial secre- tory cell metaplasia in hamsters. Exp Lung Res 1985;9: 167-75.
- Ghafouri MA, Patil KD, Kass I. Sputum changes associ- ated with the use of ipratropium bromide. Chest 1984;86:387-93.
- Stockley RA, Hill SL, Morrison HM, Starkie CM. Elastolytic activity of sputum and its relation to puru- lence and to lung function in patients with bronchiecta- sis. Thorax 1984;39:408-13.
- Suter S, Schaad UB, Tegner H, Ohlsson K, Desgrandchamps D, Waldvogel FA. Levels of free gran- ulocyte elastase in bronchial secretions from patients with cystic fibrosis: effects of antimicrobial treatment against Pseudomonas aeruginosa. Infect Dis 1986;153:902-9.
- Stockley RA, Hill SL, Burnett D. Proteinases in chronic lung infection. Ann NYAcad Sci 1991;624:257-66.
- Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. Clin Invest 1990;85:682-9.
- Amatini R, Wilson R, Rutman A, Read R, Ward C, Burnett D, et al. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respi- ratory epithelium. Am J Respir CeU Mol Biol 1991;4:26-32.
- Kercsmar CM, Davis PB. Resistance of human tracheal epithelial cells to killing by neutrophils, neutrophil elas- tase, and Pseudomonas elastase. Am J Respir Cell MolBiol 1993;8:56-62.
- Sponer M, Nick HP, Schnebli HP. Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa. Biol Chem Hoppe Seyler 1991;372:963-70.
- Tournier J-M, Jacquot N, Puchelle E, Bieth JG. Evidence that Pseudomonas aeruginosa elastase does not inactivate the bronchial inhibitor in the presence of leukocyte elas- tase. Studies with cystic fibrosis sputum and with pure proteins. Am Rev Respir Dis 1985;132:524-8.
- Rickard KA, Taylor J, Rennard SI. Observations of devel- opment of resistance to detachment of cultured bovine bronchial epithelial cells in response to protease treat- ment. Am J Respir Cell Mol Biol 1992;6:414-20.
- Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysio- logic significance. Am Rev Respir Dis 1986;133:218-25.
- Idell S, Kucich U, Fein A, Kueppers F, James HL, Walsh PN, et al. Neutrophil elastase-releasing factors in bron- choalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985;132: 1098-105.
- Cochrane CG, Spragg R, Revak SD. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. Jf Clin Invest 1983;71:754-61.
- Lee CT, Fein AM, Lippman M, Holtzmann H, Kimbel P, Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syn- drome. N EnglJf Med 1981;304:192-6.
- McGuire WW, Spragg RG, Cohen AB, Cochrane CG. Studies on the pathogenesis of the adult respiratory dis- tress syndrome. J Clin Invest 1982;69:543-53.
- Christner P, Fein A, Goldberg S, Lippmann M, Abrams W, Weinbaum G. Collagenase in the lower respiratory tract of patients with adult respiratory distress syn- drome. Am Rev RespirDis 1985;131:690-5.
- Baird BR, Cheronis JC, Sandhaus RA, Berger EM, White CW, Repine JE. 02 metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs. JAppl Physiol 1986;61:2224-9.
- Cohen AB, MacArtur C, Idell S, Maunder R, Martin T, Dinarello CA, et al. A peptide from alveolar macrophages that releases neutrophil enzymes into the lungs in patients with the adult respiratory distress syn- drome. Am Rev RespirDis 1988;137:1151-8.
- Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol 1990;259:L159-84.
- Crystal RG, Ferrans VJ, Basset F. Biologic basis of pul- monary fibrosis. In: Crystal RG, West JB, eds. The lung. New York: Raven Press, 1991:2031-46.
- Thrall RS, Barton RW, D'Amato DA, Sulavik SB. Differential cellular analysis of bronchoalveolar lavage fluid obtained at various stages during development of bleomycin-induced pulmonary fibrosis in the rat. Am Rev RespirDis 1982;126:488-92.
- Glassroth JL, Bernado J, Lucey EC, Center DM, Jug- Legg Y, Snider GL. Interstitial pulmonary fibrosis induced in hamsters by intratracheally administered chrysotile asbestos. Am Rev Respir Dis 1984;130:242-8.
- Garcia JGN, James HL, Zinkgraf S, Perlman MB, Keogh BA. Lower respiratory tract abnormalities in rheumatoid interstitial lung disease: potential role of neutrophils in lung injury. Am Rev Respir Dis 1987;136:811-7.
- Ognibene FP, Martin SE, Parker MM, Schlesinger T, Roach P, Burch C, et al. Adult respiratory distress syn- drome in patients with severe neutropenia. N Engl J Med 1986;315:547-51.
- Clark JG, Kuhn C III. Bleomycin-induced pulmonary fibrosis in hamsters: effect of neutrophil depletion on lung collagen synthesis. Am Rev Respir Dis 1982;126:737-9.
- Gadek JE, Kelman JA, Fells GA, Weinberger SE, Horwizt AL, Reynolds HY, et al. Collagenase in the lower respi- ratory tract of patients with idiopathic cystic fibrosis. N EnglJ Med 1979;301:737-42.
- Weiland JE, Garcia JG, Davis WB, Gadek JE. Neutrophil collagenase in rheumatoid interstitial lung disease. JApplPhysiol 1987;62:628-33.
- O'Connor C, Odlum C, Van Breda A, Power C, Fitzgerald MX. Collagenase and fibronectin in bron- choalveolar lavage fluid in patients with sarcoidosis. Thorax 1988;43:393-400.
- Selman M, Pardo A. Potential role of proteases in pul- monary fibrosis. Ann NYAcad Sci 1991;624:297-306.
- Jordana M. Mast cells and fibrosis-who's first? Am Jf Respir Cell Mol Biol 1993;8:7-8.
- Hartman T, Ruoss SJ, Raymond WW, Seuwen K, Caughey GH. Human tryptase as a potent, cell-specific mitogen: role of signalling pathways in synergistic responses. Am J Physiol 1992;262:L528-34.
Cited by
Sorted by citations
Discrimination of Methionine Sulfoxide and Sulfone by Human Neutrophil Elastase
Leahy, D., Grant, C., Jackson, A., Duff, A., Tardiota, N., Van Haeften, J., Chen, X., Peake, J. M., Kruppa, M. D., Smith, E. T., et al. (2021) · Molecules · doi:10.3390/molecules26175344 · Cited by 2 · see citing works
- Authors
- Tetley, T. D.
- Affiliations
- Charing Cross Hospital (GB)
- Corresponding author
- Tetley, T D
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 1993-05-01
- Volume
- 48
- Issue
- 5
- Pages
- 560-565
- ISSN
- 0040-6376 (ISSN-L)
- PMC
- PMC464518
- OpenAlex
- W2133323101
- Cited by
- 140
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 1 · 2017: 5 · 2016: 3 · 2015: 7 · 2014: 1 · 2013: 2 · 2012: 3
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Thorax (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Keywords
- neutrophil elastase, emphysema, pulmonary fibrosis, neutrophil elastase inhibitor, protease inhibitors, proteolytic enzymes, neutrophils, macrophages, extracellular matrix, urokinase, tissue proteolysis, lung injury, smoking, acute lung injury
- MeSH terms
- Extracellular Matrix, Humans, Lung Diseases, Macrophages, Neutrophils, Pancreatic Elastase, Endopeptidases, Protease Inhibitors, Pulmonary Emphysema, Respiratory Distress Syndrome, Leukocyte Elastase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review